Ding N, Hermans KEPE, van Nijnatten TJA, Engelen SME, et al. Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patients. Eur J Cancer 2025;222:115475.
PMID: 40306118